Click here to register for a live webcast of this event.
Featured Speakers and Topics:
Dr. Jeff Elias, Professor of Neurological Surgery, University of Virginia - New England Journal of Medicine publication and FDA approval for essential tremor; new clinical data on focused ultrasound to treat Parkinson’s; and the start of the first-in-human study for epilepsy Dr. Paul Fishman, Professor of Neurology, Pharmacology and Neurobiology, University of Maryland School of Medicine- Using focused ultrasound to open the blood-brain barrier to deliver therapies for Alzheimer’s, Parkinson’s and brain tumors Dr. Joo Ha Hwang, Chief of Gastroenterology, University of Washington- Focused ultrasound as a new oncology tool to ablate cancers in the prostate and other regions as well as to enhance immunotherapy for pancreatic, breast and other cancersDr. Pejman Ghanouni, Assistant Professor of Radiology, Stanford University Medical Center- Focused ultrasound to non-invasively destroy benign and malignant soft tissue tumors and to treat painful bone conditions, such as facet joint osteoarthritis, knee, hand and hip arthritis and neuropathic pain Dr. Michael Gertner, CEO, Kona Medical- Clinical research advances in using focused ultrasound for renal denervation to reduce blood pressureAbout Focused Ultrasound TechnologyFocused ultrasound is a revolutionary, early-stage therapeutic technology with the potential to transform the treatment of many serious medical disorders. This approach uses ultrasonic energy guided by real-time imaging to treat tissue deep in the body without incisions or radiation.
A focused ultrasound system was recently approved in the US to treat essential tremor. Other FDA approved uses include prostate disease, uterine fibroids and pain from bone metastases. There are more than 50 clinical applications in various stages of research and development around the world.